e-learning
resources
Virtual 2020
Pre-Congress Content
Exhaled biomarkers of asthma and the asthma burden
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output
T. Karvonen (Tampere, Finland), A. Sepponen-Lavikko (Tampere, Finland), K. Holm (Tampere, Finland), R. Schultz (Tampere, Finland), E. Moilanen (Tampere, Finland), L. Lehtimäki (Tampere, Finland)
Source:
Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Session:
Exhaled biomarkers of asthma and the asthma burden
Session type:
E-poster session
Number:
2172
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Karvonen (Tampere, Finland), A. Sepponen-Lavikko (Tampere, Finland), K. Holm (Tampere, Finland), R. Schultz (Tampere, Finland), E. Moilanen (Tampere, Finland), L. Lehtimäki (Tampere, Finland). Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output. 2172
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Acinar effect of inhaled steroids therapy evidenced by exhaled nitric oxide
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001
Salbutamol temporarily increases the bronchial production of nitric oxide
Source: Eur Respir J 2007; 30: Suppl. 51, 63s
Year: 2007
Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Features of production nitric oxide at patients with a bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 445s
Year: 2006
Are bronchial hyperresponsiveness and exhaled nitric oxide related in asthma? Effects of fluticasone
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis
Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases
Year: 2007
The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Partitioning of alveolar and conducting airway nitric oxide in asthma of different severity
Source: Eur Respir J 2004; 24: Suppl. 48, 328s
Year: 2004
Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept